The US Court of Appeals for the Federal Circuit has upheld that the Myriad Genetics composition of matter claims covering isolated DNA of the BRCA 1 and BRCA 2 genes are patent-eligible material under Section 101 of the US Patent Act. ...
Tags: BRCA 1 genes, BRCA 2 genes, isolated DNA, Myriad Genetics